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1. Introduction 
We have proposed [ 1,2] negative cooperativity for 
human liver L-type pyruvate kinase, a phenomenon 
also observed in [3-71: Lineweaver-Burk plots V’-’ 
versus [phosphoenolpyruvatel-’ were straight lines 
at low phosphoenolpyruvate concentrations, and 
bent downward near they axis (high phosphoenol- 
pyruvate concentrations). Our conclusions were 
drawn from experiments performed at Mg2+total = 
12 mM or 20 mM [ 1,2]. However, phosphoenolpyruvate 
has been proposed to bind Mg2’+,, with a K,, = 
5.5 X IO-” M-’ at 25°C [S]. So, at high phosphoenol- 
pyruvate concentrations Mgz+free would be removed 
from the reaction mixture. We investigated the 
hypothesis that the phenomenon interpreted as nega- 
tive cooperativity [ 1,2] is in fact due to removing 
inhibitory MgZffree from the reaction mixture at high 
phosphoenolpyruvate concentrations. Our results are 
in favour of this hypothesis. 
2. Materials and methods 
NADH (disodium salt), ADP (disodium salt), fruc- 
tose-l ,6-diphosphate (trisodium salt), phosphoenol- 
pyruvate (tricyclohexylammonium salt) and lactate 
dehydrogenase (rabbit muscle, 550 IU/mg) were 
obtained from Boehringer, Mannheim. Dithiotreitol 
and bovine serum albumin were from Sigma, St Louis. 
All reagents were of the highest purity available. 
Human liver L-type pyruvate kinase was purified 
by the method in [9]. The preparation had spec. act. 
360 IU/mg, and was stored as an (NH,),S04-precipitate 
at -80°C. Prior to use the enzyme was dialyzed 
extensively at +4”C, against the buffer used in the 
kinetic experiments, containing 0.5 M sucrose, 1 mM 
dithiotreitol, and 1 mg/ml bovine serum albumin for 
stabilisation. 
Pyruvate kinase activity was measured either at 
25°C or 37°C by the method in [lo]. Two buffer 
systems were used. Buffer A (the buffer used in [ 1,2]) 
contained 0.1 M triethanolamineeHC1 (pH 7.5) at 
37”C, 0.1 M KCl, 20 mM MgCl,? 0.1 M NADH, 10 IU 
lactate dehydrogenase (not dialysed), 1 mM dithio- 
treitol and 0.1 mM fructose-l ,6_diphosphate. Buffer B 
contained 0.01 M Tris-IlCl (pH 8.0) at 25”C, 0.05 M 
KCl, 0.1 mM NADH, 10 IU lactate dehydrogenase 
(dialysed against the assay buffer), 1 mM dithiotreitol 
and 0.1 mM fructose-l ,6-diphosphate. In buffer B 
either Mg2’total was kept constant at 20 mM, or 
Mg2+free was kept constant at 1, 10 or 20 mM using 
K, = 5.5 X 10d3 M-’ (25°C) for the MgPEP- 
complex [9] and K, = 3.39 X 10e4 M-r (25°C) for 
the MgADP- complex (11). [Phosphoenolpyruvate]total 
was 0.02-10 mM; ADP,,,, was kept at 3 mM. The 
enzyme was preincubated in the reaction mixture 
containing all ligands except ADP for 5 - 10 min; the 
reaction was initiated by the addition of ADP. 
3. Results and discussion 
When a Lineweaver-Burk plot was made in buffer A 
(Mg2+total = 20 mM) at 25 or 37”C, a linear relationship 
was observed at low phosphoenolpyruvate concentra- 
tions (PEP,,,t < 0.5 mM). However, at high phos- 
phoenolpyruvate concentrations the curve bends 
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Fig.1. Lineweaver-Burk (L-B) plots V-’ versus [phosphoenol- 
pyruvate] -I of human liver L-type pyruvate kinase.(*-•) 
L-B plot in buffer A at 20 mM Mg2’totat at 25°C. (O--O) 
L-B plot in buffer B at Mg*+free = 10 mM at 25°C. The dif- 
ference in Vnlax is due to the use of different enzyme con- 
centrations. 
downward, a phenomenon that we [ 1,2] interpreted as 
negative cooperativity. A similar phenomenon was 
observed in buffer B when Mgz+total was kept at 20 mM 
(fig.]). However, when a Lineweaver-Burk plot was 
made in buffer B at Mg”t,, = l,lOor20mM(at 
25”C), a linear relationship was found at all phos- 
phoenolpyruvate concentrations tested (fig.1). 
These results suggest hat the phenomenon inter- 
preted as negative cooperativity [ 1,2] is in fact due 
to removing inhibitory Mg2cfree from the reaction 
mixture at high phosphoenolpyruvate concentrations. 
In order to check whether indeed phosphoenol- 
pyruvate binds Mg2’free in our assay system, we made 
Vversus[Mg2’to,,J]plots at 37°C of human liver L-type 
pyruvate kinase in buffer A (20 mM Mg2+to+&, at a 
few different phosphoenolpyruvate concentrations. 
At phosphoenolpyruvate = 1 mM (the enzyme is fully 
saturated with this substrate), we find a maximum in 
the plot at -1.5 mM Mg2+total. At phosphoenol- 
pyruvate = 20 mM, we find a maximum in the plot 
around 10 mM Mg2+totaJ. Because the true substrates 
of human liver L-type pyruvate kinase are not known, 
a full interpretation of these results cannot be given. 
However it is clear, that the shift in position of the 
maximum can only be caused by an interaction 
between Mg*’ and phosphoenolpyruvate. Because in 
both cases the enzyme is fully saturated with phos- 
phoenolpyruvate, this interaction cannot be mediated 
through the enzyme, and is therefore probably simply 
an ionic binding process in solution. SO, for example, 
at phosphoenolpyruvate = 10 mM, in the buffer 
system with Mg*‘,,,J = 12 mM, the concentration of 
the mhibrtor Mg2tfrce is reduced by a factor of -2, 
compared to in the absence of phosphoenolpyruvate, 
resulting in a more active enzyme. 
For the L-type pyruvate kinase forms from human 
erythrocytes, negative cooperativity would also be an 
artefact of a varying Mgzffree concentration, just as 
for the liver enzyme. So, in kinetic studies on L-type 
pyruvate kinase, Mgzefree must be kept carefully 
under control. 
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